Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: A double-blind, placebo-controlled, randomized crossover trial

Circulation

Volumn 94, Issue 12, 1996, Pages 3184-3189

  Marcus, Lee S ^b   Hart, Douglas ^b   Packer, Milton ^b   Yushak, Madeline ^b   Medina, Norma ^b   Danziger, Robert S ^b   Heitjan, Daniel F ^b   Katz, Stuart D ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b NONE

Author keywords

drugs; heart failure; hemodynamics; natriuretic peptides; pharmacology

Indexed keywords

ATROPINE; BRAIN NATRIURETIC PEPTIDE; CREATININE; CYCLIC GMP; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; LOOP DIURETIC AGENT; NITRIC ACID DERIVATIVE; NITROGEN; OXYGEN; POTASSIUM; SODIUM; UREA; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT ATRIUM PRESSURE; HEMODYNAMICS; HUMAN; HYPOTENSION; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SCINTIANGIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; URINARY EXCRETION;

EID: 0030481630     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3184     Document Type: Article

References (35)

1. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988;332:78-81.
2. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.
3. Hosoda K, Nakao K, Mukoyama M, Saito Y, Jougasaki M, Shirakami G, Suga S, Ogawa Y, Yasue H, Imura H. Expression of brain natriuretic peptide gene in human heart: production in the ventricle. Hypertension. 1991;17:1152-1155.
4. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, Nakao K, Imura H. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation. 1993;87:464-469.
5. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation. 1992;86:1081-1088.
6. Deutsch A, Frishman WH, Sukenik D, Somer BG, Youssri A. Atrial natriuretic peptide and its potential role in pharmacotherapy. J Clin Pharmacol. 1994;34:1133-1147.
7. Moe GW, Grima EA, Wong NL, Howard RJ, Armstrong PW. Dual natriuretic peptide system in experimental heart failure. J Am Coll Cardiol. 1993;22:891-898.
8. Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJF, Scarborough RM, Lewicki JA. Atrial natriuretic factor in normal subjects and heart failure patients. J Clin Invest. 1986;78:1362-1374.
9. Fifer MA, Molina CR, Quiroz AC, Giles TD, Herrmann HC, De Scheerder IR, Clement DL, Kubo S, Cody RJ, Cohn JN, Fowler MB. Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. Am J Cardiol. 1990;65:211-216.
10. Crazier IG, Nicholls MG, Ikram H, Espiner EA, Gomez HJ, Warner NJ. Haemodynamic effects of atrial peptide infusion in heart failure. Lancet. 1986;2:1242-1245.
11. Saito H, Ogihara T, Nakamaru M, Hara H, Higaki J, Rakugi H, Tateyama H, Minamino T, Iinuma K, Kumahara Y. Hemodynamic, renal, and hormonal responses to alpha-human atrial natriuretic peptide in patients with congestive heart failure. Clin Pharmacol Ther. 1987; 42:142-147.
12. Molina CR, Fowler MB, McCrory S, Peterson C, Myers BD, Schroeder JS, Murad F. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. J Am Coll Cardiol. 1988;12:175-186.
13. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Mukoyama M, Saito Y, Nakao K, Imura H. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 1991;84:1581-1588.
14. Packer M, Medina N, Yushak M. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Circulation. 1985;71:761-766.
15. Zhou HL, Fiscus RR. Brain natriuretic peptide (BNP) causes endothelium-independent relaxation and elevation of cyclic GMP in rat thoracic aorta. Neuropeptides. 1989;14:161-169.
16. Holmes SJ, Espiner EA, Richards AM, Yandle TO, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993; 76:91-96.
17. La Villa G, Fronzaroli C, Lazzeri C, Porciani C, Bandinelli R, Vena S, Messeri G, Franchi F. Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man. J Clin Endocrinol Metab. 1994;78:1166-1171.
18. Wong SKF, Garbers DL. Receptor guanylyl cyclases. J Clin Invest. 1992;90:299-305.
19. Packer M, LeJemtel TH. Physiologic and pharmacologic determinants of vasodilator response: a conceptual framework for rational drug therapy for chronic heart failure. Prog Cardiovasc Dis. 1982; 24:275-292.
20. Keren G, Katz S, Strom J, Sonnenblick EH, LeJemtel TH. Dynamic mitral regurgitation: an important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation. 1989;80:306-313.
21. Morita H, Nishida Y, Motochigawa H, Kangawa K, Minamino N, Matsuo H, Hosomi H. Effects of brain nalriuretic peptide on renal nerve activity in conscious rabbits. Am J Physiol. 1989;256: R792-R796.
22. Luk JK, Wong EF, Sun A, Wong NL. Cyclic guanosine monophosphate responses to atrial nalriuretic factor, brain natriuretic peptide, but not C-type natriuretic peptide, and the characterization of their receptors in rat medullary thick ascending limb. Metab Clin Exp. 1994;43:1531-1535.
23. Cozza EN, Foecking MF, del Carmen Vila M, Gomez-Sanchez CE. Adrenal receptors for natriuretic peptides and inhibition of aldosterone secretion in calf zona glomerulosa cells in culture. Acta Endocrinol. 1993;129:59-64.
24. Tsunoda K, Mendelsohn FAO, Sexton PM, Chai SY, Hodsman GP, Johnston CI. Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure. Circulation. 1988;62:155-161.
25. Moe GW, Canepa-Anson R, Armstrong PW. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure. J Cardiovasc Pharmacol. 1992;19:691-700.
26. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, Kinoshita M. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation. 1993;87:70-75.
27. Riegger GA, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, Pascher EW, Kochsiek K. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation. 1988;77: 398-406.
28. Schiffrin EL. Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure. Clin Sci. 1988;74:213-218.
29. Kenny AJ, Bourne A, Ingram J. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11, Biochem J. 1993;291:83-88.
30. Abassi ZA, Kelly G, Colomb E, Klein H, Keiser HR. Losartan improves the natriuretic response to ANF in rats with high-output heart failure. J Pharmacol Exp Ther. 1994;268:224-230.
31. Raya TE, Lee RW, Westhoff T, Goldman S. Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure. Circulation. 1989;80:1886-1892.
32. Biollaz J, Nussberger J, Porchet M, Brunner-Ferber F, Otterbein ES, Gomez H, Waeber B, Brunner HR. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers. Hypertension. 1986; 8(suppl II):II-96-II-105.
33. Floras JS. Sympathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation. 1990;81:1860-1873.
34. Atchison DJ, Ackermann U. The interaction between atrial natriuretic peptide and cardiac parasympathetic function. J Auton Nerv Syst. 1993;42:81-88.
35. Nemerovski M, Shah PK. Syndrome of severe bradycardia and hypotension following sublingual nitroglycerin administration. Cardiology. 1981;67:180-189.